Literature DB >> 8443805

Fluence rate effects in photodynamic therapy of multicell tumor spheroids.

T H Foster1, D F Hartley, M G Nichols, R Hilf.   

Abstract

EMT6/Ro spheroids approximately 500 microns in diameter were subjected to photodynamic therapy administered at various incident radiation fluence rates. Following 24 h incubation with 10 micrograms/ml Photofrin, groups of spheroids were irradiated at 630 nm with an identical fluence of 60 J/cm2, delivered at fluence rates ranging from 25 to 200 mW/cm2. After treatment, spheroids were dissociated, cell yields were determined, and surviving cells were assayed for their colony-forming ability. A surviving fraction was calculated for each treatment group by computing the product of the fractional cell yield and the plating efficiency. The results exhibit a strong dependence on the fluence rate, with surviving fractions decreasing from approximately 0.5 to 0.07 as the incident fluence rate was lowered from 200 to 25 mW/cm2. These data were analyzed using a mathematical model of photochemical oxygen consumption in spheroids undergoing photodynamic therapy. Calculations showed that therapy-induced oxygen consumption creates hypoxic volumes within which cells would be protected from singlet oxygen-mediated damage and that the magnitude of these hypoxic volumes depends on the radiation fluence rate. The fluence rate dependence of the spheroid cell survival was consistent with such an interpretation.

Entities:  

Mesh:

Year:  1993        PMID: 8443805

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids.

Authors:  Steen J Madsen; Chung-Ho Sun; Bruce J Tromberg; Henry Hirschberg
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

2.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm.

Authors:  B C Wilson; M S Patterson; L Lilge
Journal:  Lasers Med Sci       Date:  1997-10       Impact factor: 3.161

Review 3.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

4.  Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model.

Authors:  Jonathan P Celli; Imran Rizvi; Conor L Evans; Adnan O Abu-Yousif; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

5.  Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.

Authors:  Alyssa M Master; Megan Livingston; Nancy L Oleinick; Anirban Sen Gupta
Journal:  Mol Pharm       Date:  2012-07-19       Impact factor: 4.939

6.  Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate.

Authors:  Theresa M Busch; Hsing-Wen Wang; E Paul Wileyto; Guoqiang Yu; Ralph M Bunte
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

7.  Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy.

Authors:  Tao Xu; Yingxing Li; Xing Wu
Journal:  Lasers Med Sci       Date:  2004-10-26       Impact factor: 3.161

8.  Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy.

Authors:  Tao Xu; Yingxing Li; Xing Wu
Journal:  Lasers Med Sci       Date:  2005       Impact factor: 3.161

9.  The study of the characteristic of photocytotoxicity under high peak power pulsed irradiation with ATX-S10Na(II) in vitro.

Authors:  Sayaka Ohmori; Kensuke Masuda; Masatake Yoshida; Tsunenori Arai; Susumu Nakajima
Journal:  Lasers Med Sci       Date:  2005-07-09       Impact factor: 3.161

10.  ALA- and ALA-ester-mediated photodynamic therapy of human glioma spheroids.

Authors:  Henry Hirschberg; Chung-Ho Sun; Bruce J Tromberg; Steen J Madsen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.